Although the differences in responsiveness in different subtypes of sleep apnea did not reach statistical significance, acetazolamide's effect on AHI in the case of OSA and/or CSA was demonstrated to be dose dependent by reaching a plateau at approximately a 500 mg/day dose.
← all excerpts
Acetazolamide-Assisted Weaning From Mechanical Ventilation in a Child With Mixed Sleep Apnea: A Case Report.
1
—
—